Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
0.9390
-0.0209 (-2.18%)
At close: Sep 29, 2026, 4:00 PM EDT
0.9200
-0.0190 (-2.02%)
After-hours: Sep 29, 2026, 7:43 PM EDT
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $4.2 million as of September 29, 2026. Its market cap has increased by 88.45% in one year.
Market Cap
4.20M
Enterprise Value
-5.32M
1-Year Change
88.45%
Ranking
Category
Stock Price
$0.94
ChartMarket Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.42M to $4.20M, a decrease of -93.78%. That is a compound annual growth rate of -43.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 4.20M | 246.62% |
| Dec 31, 2025 | 1.21M | -55.01% |
| Dec 31, 2024 | 2.69M | 78.09% |
| Dec 29, 2023 | 1.51M | -80.24% |
| Dec 30, 2022 | 7.65M | -84.67% |
| Dec 31, 2021 | 49.89M | -26.00% |
| Nov 10, 2021 | 67.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 20/20 Biolabs | 5.55M |
| Trinity Biotech | 5.50M |
| Phaos Technology Holdings (Cayman) Limited | 5.30M |
| Intelligent Bio Solutions | 5.15M |
| WORK Medical Technology Group LTD | 4.62M |
| INVO Fertility | 4.51M |
| Aethlon Medical | 4.47M |
| Adagio Medical Holdings | 4.33M |